{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:42:18Z","timestamp":1779147738682,"version":"3.51.4"},"reference-count":26,"publisher":"Microbiology Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1099\/jmm.0.000808","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T13:12:50Z","timestamp":1532697170000},"page":"1402-1409","source":"Crossref","is-referenced-by-count":9,"title":["Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile"],"prefix":"10.1099","volume":"67","author":[{"given":"Kirsty","family":"Skinner","sequence":"first","affiliation":[{"name":"1\u200bEvotec (UK), Alderley Park, Cheshire, SK10 4TG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Birchall","sequence":"additional","affiliation":[{"name":"1\u200bEvotec (UK), Alderley Park, Cheshire, SK10 4TG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Corbett","sequence":"additional","affiliation":[{"name":"1\u200bEvotec (UK), Alderley Park, Cheshire, SK10 4TG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Thommes","sequence":"additional","affiliation":[{"name":"1\u200bEvotec (UK), Alderley Park, Cheshire, SK10 4TG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Locher","sequence":"additional","affiliation":[{"name":"2\u200bActelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil, Switzerland"},{"name":"\u2020\u200bPresent address: Idorsia Pharmaceuticals Ltd., Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-29"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.1554"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.073"},{"key":"R4","first-page":"901","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"58","author":"Louie","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2008.08.012"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70374-7"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00384-17"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01831-13"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01830-13"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2013.02.003"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt411"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00504-15"},{"key":"R13","volume-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard -","year":"2007"},{"key":"R14","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard -","year":"2018"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv006"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.029470-0"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024894"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis339"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis453"},{"key":"R20","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/JCM.36.8.2240-2247.1998","article-title":"A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates","volume":"36","author":"Rupnik","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5710-5714.2004"},{"key":"R22","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/IAI.66.5.2018-2025.1998","article-title":"Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection","volume":"66","author":"Kink","year":"1998","journal-title":"Infect Immun"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05873-11"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-9-r102"},{"key":"R25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/IAI.25.1.191-201.1979","article-title":"Purification and characterization of Clostridium difficile toxin","volume":"25","author":"Rolfe","year":"1979","journal-title":"Infect Immun"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2000.tb09122.x"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000808?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T21:37:02Z","timestamp":1604698622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.000808","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}